Leprosy Review
Published by British Leprosy Relief Association (Journal Finder)
ISSN : 0305-7518
Abbreviation : Lepr. Rev.
Aims & Scope
Leprosy Review is an Open Access peer reviewed journal including original papers on all aspects of leprosy.
Topics published include research into the medical, physical and social aspects of leprosy and information relevant to leprosy control.
We publish original research, short reports, case studies and reviews.
The vision of the journal is to improve the management and control of leprosy and its consequences, by publishing relevant research and sharing experiences and best practices.
View Aims & ScopeMetrics & Ranking
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 0.302 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q3 |
h-index
| Year | Value |
|---|---|
| 2024 | 52 |
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Apc url
- License
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
TWO-AND-A-HALF YEARS' EXPERIMENTAL WORK ON THE SULPHONE GROUP OF DRUGS
Citation: 24
Authors: R. G., K., H., H.
-
Type 1 reaction, neuritis and disability in leprosy. What is the current epideiniological situation?
Citation: 22
Authors: C., P. E. M.
-
The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome
Citation: 19
Authors: PAUL, SHIBRU, KETSELA, PETER, DIANA N. J.